来自FAERS数据库的rimegepant的现实世界不良事件研究
1Department of Neurology, Deqing People's Hospital, Huzhou, Zhejiang, China.
Expert opinion on drug safety
|October 16, 2024
概括
这项研究分析了6659份rimegepant不良药事件报告,将药物过度使用头痛和鼻确定为重大问题. 需要进一步调查未列出的副作用,如和恐慌发作.
科学领域:
- 药物监督 药物监督 药物监督
- 临床安全研究 临床安全研究
- 药品安全监督 药品安全监督
背景情况:
- 里米盖潘特是一种用于治疗某些疾病的药物.
- 了解其安全概况对于患者护理至关重要.
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 是药物安全的关键数据来源.
研究的目的:
- 使用FAERS数据对rimegepant的安全性进行全面评估.
- 为了确定与rimegepant相关的潜在不良药物事件 (ADEs).
- 为了发现以前未被认可的安全问题.
主要方法:
- 从FAERS (2020年第二季度 - 2024年第一季度) 下载了与rimegepant有关的报告.
- 使用不成比例分析来检测安全信号.
- 分析了6659份药物不良事件报告,里梅是主要的疑似药物.
主要成果:
- 综合性疾病和注射部位状况成为重要的器官系统类别.
- 信号强度高的顶级ADEs包括药物过量使用头痛,鼻和张力头痛.
- 常见的ADEs是恶心,异常感觉和腹部上部疼痛;值得注意的未列出的ADEs包括头和恐慌发作.
结论:
- 该研究发现了以前未被承认的rimegepant的安全问题.
- 新的安全方面需要进一步的临床研究.
- 虽然有效,但rimegepant可能会带来需要探索的额外风险.
更多相关视频
相关概念视频
Pharmacovigilance
783
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
783
Antiepileptic Drugs: Potassium Channel Activators
148
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
148
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Relative Risk
122
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
122
Hazard Ratio
91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
91
Cardiomyopathy IV: Restrictive Cardiomyopathy
2
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
2


